
Phase 3 PHOENIX trial for oral GA treatment completes enrollment
Belite Bio, Inc. has completed enrollment in the PHOENIX trial. The PHOENIX study is a 24-month, randomized, double-masked, placebo-controlled, multicenter, pivotal Phase 3 trial for this oral medication. This trial will evaluate the safety and …